Keywords: ucb, cimzia, shows, efficacy, weeks, belgian, drugmaker
UCB's Cimzia shows efficacy at 80 weeks
Article | 28 May 2007
Belgian drugmaker UCB says that new data presented at Digestive Disease Week 2007 demonstrated long-term response and remission in Crohn's disease ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
